The Chinese government is very serious about turning China into a biotechnology powerhouse and is spreading enough money around to make it happen.
The latest. A grant from China’s National Development and Reform Commission to Sinovac (NYSE:SVA) has allowed it to expand its vaccine production capacity to 20 million doses annually.
I’ve been following Sinovac for a while and am very, very interested in it. I haven’t pulled the trigger yet, but it is getting cheap enough that I may soon.
Related Posts
- IMF still see bright future for China (10/10/08)
- Baskings Robbins targets China (07/31/08)
- Suntech targets the U.S. (10/02/08)
- The cloudy future of Lehman Brothers (09/11/08)
- Sinovac gets huge order (09/06/09)
